Russell Investments Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $254K | Sell |
14,924
-14,305
| -49% | -$243K | ﹤0.01% | 2579 |
|
2025
Q1 | $571K | Sell |
29,229
-146,952
| -83% | -$2.87M | ﹤0.01% | 2256 |
|
2024
Q4 | $4.37M | Sell |
176,181
-11,664
| -6% | -$289K | 0.01% | 1237 |
|
2024
Q3 | $4.6M | Buy |
187,845
+18,284
| +11% | +$448K | 0.01% | 1233 |
|
2024
Q2 | $3.97M | Buy |
169,561
+25,733
| +18% | +$603K | 0.01% | 1263 |
|
2024
Q1 | $4.75M | Buy |
143,828
+6,102
| +4% | +$202K | 0.01% | 1194 |
|
2023
Q4 | $3.75M | Buy |
137,726
+115
| +0.1% | +$3.13K | 0.01% | 1279 |
|
2023
Q3 | $3.31M | Buy |
137,611
+21,251
| +18% | +$511K | 0.01% | 1280 |
|
2023
Q2 | $3.72M | Buy |
116,360
+7,602
| +7% | +$243K | 0.01% | 1220 |
|
2023
Q1 | $3.33M | Buy |
108,758
+17,496
| +19% | +$536K | 0.01% | 1295 |
|
2022
Q4 | $3.57M | Sell |
91,262
-799
| -0.9% | -$31.2K | 0.01% | 1264 |
|
2022
Q3 | $4.38M | Buy |
92,061
+1,849
| +2% | +$88.1K | 0.01% | 1126 |
|
2022
Q2 | $3.49M | Sell |
90,212
-8
| -0% | -$310 | 0.01% | 1280 |
|
2022
Q1 | $5.17M | Buy |
90,220
+894
| +1% | +$51.2K | 0.01% | 1139 |
|
2021
Q4 | $7.12M | Buy |
89,326
+18,303
| +26% | +$1.46M | 0.01% | 1066 |
|
2021
Q3 | $6.18M | Buy |
71,023
+10,106
| +17% | +$879K | 0.01% | 1128 |
|
2021
Q2 | $7.84M | Buy |
60,917
+33,537
| +122% | +$4.32M | 0.01% | 1067 |
|
2021
Q1 | $2.19M | Buy |
27,380
+21,565
| +371% | +$1.72M | ﹤0.01% | 1830 |
|
2020
Q4 | $474K | Buy |
+5,815
| New | +$474K | ﹤0.01% | 2453 |
|